Table 1. Features of Possible Bioterrorism Agents.

Disease Mortality Rate Typical Incubation Period Vaccine Available Treatment Available Precautions Needed
Anthrax, Inhalation High without treatment
  • Usual 1-7 d
  • Up to 60 d
  • Effective
  • Restricted availability
  • Antibiotic
  • Supportive
Supportive Standard (barrier) only
Anthrax, Cutaneous Low
  • Usual 1-7 d
  • Up to 60 d
  • Effective
  • Restricted availability
Antibiotic
  • Standard
  • Contact for draining lesions
Smallpox Moderate
  • Usual 10-12 days
  • Rarely as early as 3 or late as 17 days
  • Effective before and after exposure
  • Restricted availability
  • Supportive
  • Immune globulin
  • Experimental antiviral
Highly contagious;
  • Standard
  • Droplet
  • Airborne
Plague (pneumonic) 100% untreated 1-4 days Licensed, limited availability Antibiotics Highly contagious;
  • Standard
  • Droplet
Botulism High without treatment
  • 12-36 hours
  • Occasionally longer
No
  • Antitoxin
  • Supportive
Standard
Tularemia (pulmonary) Moderate without treatment Usually 3-5 days; varies with strain and innoculum
  • Limited availability; not post-exposure
  • Antibiotics Standard
  • Antibiotics
Standard
Viral hemorrhagic fevers Varies according to virus, ranging from <1% to 50-90% Varies according to virus, ranging from 1-2 days to a week or more
  • Limited availability: Yellow Fever vaccine
  • Several other vaccines under development
    • Supportive
    • Antiviral agents show some promise for some viral infections
      Most are highly contagious:
      • Standard
      • Droplet
      • Airborne

        Table 2. Clinical Findings, Differential Diagnosis and Tests for BT and Other Agents of Public Health Importance.

        Disease Important Findings Differential Diagnosis Important Tests Precautions Other
        Anthrax, Inhalation
        • Mild "URI" prodrome, followed by
        • Abrupt onset severe pulmonary symptoms
        • Chest pain
        • Respiratory distress inconsistent with degree of pulmonary infiltration
        • Rapid progression
        • Large pleural effusions
        • Headache
        • Meningeal symptoms
        • Pulmonary embolism
        • Inhalation exposure to toxic or caustic agent
        • Dissecting aortic aneurysm
        • Chest X-ray, CT Scan, or MRI: hilar adenopathy with widened mediastinum pleural effusions; patchy infiltrates
        • Blood or CSF culture with large, gram-positive "boxcar" shaped rods; sputum smear may be unremarkable
        • Blood, CSF cultures positive for non-motile, non-hemolytic Bacillus species
        Standard barrier precautions; no risk of person-to-person spread of Anthrax
        • Immediately notify public health authorities;
        • Immediately notify law enforcement agencies if BT suspected
        • Immediately hospitalize in intensive care
        • Start aggressive antimicrobial therapy and supportive treatment immediately
        Anthrax, Cutaneous
        • Painless pruritic papule, progressing to vesicles and then a black eschar
        • Regional adenipathy
        • low grade fever
        • Brown recluse spider bite
        • Orf (sheep-associated, viral, cutaneous infection more common in New Zealand but also found in U.S.)
        Lesion demonstrates typical microorganisms on microscopic and culture exams
        • Standard precautions
        • Contact precautions for draining lesions
        • Immediately notify public health authorities;
        • Immediately notify law enforceent agencies if BT suspected
        • Start aggressive antimicrobial therapy
        Pneumonic Plague
        • Severe bilateral pneumonia
        • Hemoptysis
        • Hypoxemia and cyanosis
        • Shock
        • Headache
        • Severe community acquired pneumonia
        • Hantavirus pulmonary syndrome
        Gram-negative coccobacilli or bacilli in sputum or blood (clasically have a "safety-pin" appearance on Wrights or Giemsa stain Communicable by droplet spread:
        • Standard barrier precautions
        • plus droplet precautions<
          • Immediately notify public health authorities;
          • Immediately notify law enforcement agencies if BT suspected
          • Immediately hospitalize in intensive care
          • Start aggressive antimicrobial therapy and supportive treatment immediately
          • Encourage family and close friends to remain for epidemiologic interviews; obtain contact information for all known recent close contacts and exposures for public health follow-up
          Smallpox
          • 2-4-day non-specific prodrome with fever
          • Fever may subside when rash develops
          • Vesicular, then pustular, rash, which tends to erupt in a single, synchronized crop of lesions (in contrast to chickenpox)
          • Rash begins on the face and distal extremities, sometimes involving palms and soles, and spreads centrally (vs. chickenpox, which most prominent on the trunk and less prominent peripherally)
          • Headache
          • Delirium
          • Vomiting
          • Back pain
          • Chicken pox
          • Vaccinia side effects
          • Disseminated herpes zoster
          • Monkey pox
          • Cowpox
          Virologic testing of vesicle or pustular fluid specimens in highest security laboratory (Level 4)
          • Standard
          • Airborne
          • Contact
          • Immediately notify public health authorities;
          • Immediately notify law enforcement agencies if BT suspected
          • Immediately hospitalize in intensive care with appropriate isolation facilities
          • Seek expert advice about experimental antiviral treatments
          • Encourage family and close friends to remain for epidemiologic interviews; obtain contact information for all known recent close contacts and exposures for public health follow-up
          Botulism
          • Acute bilateral descending flaccid paralysis beginning with cranial nerve palsies
          • Patients usually alert and afebrile
          • Important early symptoms include blurred vision, diplopia and dry mouth
          • Guillain-Barre Syndrome
          • Myasthenia gravis
          • Tick paralysis
          • Eaton-Lambert syndrome
          • Toxic exposure to organophosphates
          • Normal spinal fluid
          • EMG shows normal nerve conduction velocity and normal sensory findings but shows facilitation of muscle action potential on repetitive nerve stimulation
          • Serum for mouse neutralization bioassay conducted by specialized laboratories
          Standard precautions; not transmitted from person to person
          • Supportive care is critical
          • Antitoxins may be available from public health departments
          Viral hemorrhangic fevers
          • Fever
          • Severe microvascular damage with disseminated hemorrhage
          • Petechiae
          • Shock
          • Severe headache
          • Muscle pain
          • Delirium
          • Meningococcemia
          • Thrombotic thrombocytopenic purpura (TTP)
          • Hemolytic uremic syndrome
          • Viral isolation in Biosafety level 3 or 5 facility
          • ELISA or PCR testing available for some viruses
          • Communicability varies according to virus
          • Contact precautions
          • Droplet Precautions
          • Collect patientís contact and travel information, if possible, for public health authorities
          • Notify hospital about suspicions and transfer to hospital with appropriate isolation facilities
          Tularemia
          • Fever
          • Chills and rigors
          • Headache
          • Initial sore throat
          • Non-productive cough
          All influenza-like illnesses
          • Small gram-negative coccobacilli in pulmonary secretions
          • Sputum and blood culture
          • Rapid testing with DFA, PCR, or antigen-detection
          • CXR shows peribronchial infiltrates
          • Pleural effusions common
          • Standard Precautions
          • No person-to-person transmission